Massachusetts General Hospital. (2014, December - 2017, February). Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD). Identifier NCT01920555*.* https://clinicaltrials.gov/ct2/show/NCT01920555?term=NCT01920555&draw=2&rank=1